The only oncology specific patient portal solution that connects cancer patients to their healthcare team, their own health records, and the right information at the right time.
(9/15/2011 Seattle, WA) – Navigating Cancer’s Patient Engagement Portal, the industries only oncology specific solution that can integrate with any electronic health record (EHR) system, has received the federal government’s “meaningful use” stamp of approval by earning (EHR) modular certification. The designation officially deems Navigating Cancer’s solution capable of enabling healthcare providers to qualify for funding under the American Recovery and Reinvestment Act (ARRA). Tested and certified under the Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB) program, Navigating Cancer’s solution is 2011/2012 compliant in accordance with the criteria adopted by the Secretary of Health and Human Services.
“We’re excited to help our customers achieve meaningful use and qualify for incentive funds under ARRA. By combining Navigating Cancer’s Patient Engagement Portal with any certified EHR, oncology practices can quickly achieve meaningful use certification while saving time and money, and improving patient care. We see patient engagement as a way to transform healthcare and are committed to delivering the best patient portal experience to help our customers provide patient centered care,” said Gena Cook, Founder and CEO of Navigating Cancer.
This EHR Module is 2011/2012 compliant and has been certified by Drummond Group, an ONC-ATCB, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. Navigating Cancer, Inc., certified on 9/8/2011, Patient Engagement Portal version 3.9, Certification #09082011-1330-6, completed EHR certification of the following: 170.302 G, H, M, O‐V 170.304 C, F‐I.